Skip to content
Delayed ~15 min

TRVI TREVI THERAPEUTICS

Health Care · Russell 2000

Next earnings: Mon 9 Nov 2026 · after market close

What 16 analyst firms say about TREVI THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

14.33 USD+1.52 (+11.87%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+95.0%to the avg target 27.94 USD+13.61 USD
Buy 17 · Hold 1 · Sell 0

18 rated views · 20 analyst/firm records · 16 firms

Latest report14 Aug 2026avg report date 15 Jun
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MGood · #78 in the index82
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8064

Recent analyst activity · last 90 days

Our tracked history has 5 reports on TRVI from 5 analyst firms in the last 90 days (16 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target and 1 left it unchanged.

No firm's latest available rating differs from its previous one.

Latest observed target change: JonesTrading raised its target from $24.00 (set 19 Mar 2026) to $28.00 on 14 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
B Riley SecuritiesMayank MamtaniBuy20 Jul 202631.00 USD
B Riley SecuritiesWilliam WoodBuy17 Jul 202631.00 USD
BMO Capital MarketsConnor MurphyBuy7 Oct 2026—
BMO Capital MarketsEvan SeigermanBuy20 Jul 202636.00 USD
Cantor FitzgeraldJosh SchimmerBuy7 Aug 202630.00 USD
Clear StreetUnnamed analystBuy14 Nov 202521.00 USD
Clear Street LLCKaveri PohlmanBuy7 May 202640.00 USD
D Boral CapitalJason KolbertBuy17 Apr 202619.00 USD
D Boral CapitalPatrick MccannBuy21 May 202619.00 USD
H.C. WainwrightBrandon FolkesBuy11 Aug 202624.00 USD
JonestradingDebanjana ChatterjeeBuy14 Aug 202628.00 USD
JonestradingJustin WalshBuy14 Aug 202628.00 USD
Leerink PartnersRoanna RuizBuy6 May 202624.00 USD
Morgan StanleyJudah FrommerBuy7 Aug 202623.00 USD
NeedhamSerge BelangerBuy20 May 202623.00 USD
OppenheimerLeland GershellBuy25 Sep 2026—
Raymond JamesRyan DeschnerBuy7 Aug 202640.00 USD
StifelAnnabel Samimy—8 May 202630.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 03:02 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.